← back to search

Xiao Han

Xuzhou Medical College · CN
Area of research
Molecular Biology · Rheumatology
Research interest
Research interests include Cancer research, Carcinogenesis, Biology, Autophagy, Breast cancer, and Sphingosine kinase 1.
h-index
citations
598
works
10
NIH funding
primary concept
email

Recent publications

Targeting estrogen mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer
Biochemistry and Biophysics Reports 2024cited by 4position: middledoi
Excess folic acid intake increases DNA de novo point mutations
Cell Discovery 2023cited by 40position: middledoi
G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression
Cellular and Molecular Life Sciences 2023cited by 30position: middledoi
Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma
Journal of Cancer Research and Clinical Oncology 2023cited by 9position: middledoi
Targeting glucose‐6‐phosphate dehydrogenase by <scp>6‐AN</scp> induces <scp>ROS</scp> ‐mediated autophagic cell death in breast cancer
FEBS Journal 2022cited by 42position: middledoi
Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer
International Journal of Molecular Sciences 2022cited by 21position: middledoi
Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM)
Cell Death and Disease 2022cited by 12position: middledoi
Pyrotinib Targeted EGFR-STAT3/CD24 Loop-Mediated Cell Viability in TSC
Cells 2022cited by 6position: firstdoi
Targeting estrogen-mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer
Research Square 2022cited by 1position: middledoi
Transcriptional Regulation of the Warburg Effect in Cancer by SIX1
Cancer Cell 2018cited by 433position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhenkun Fu · Harbin Medical University8 papers (2022–2024)Zhoujun Lin · Nankai University8 papers (2022–2024)Chenggang Li · Chinese PLA General Hospital7 papers (2022–2024)Xiaolin Pei · Zhejiang University6 papers (2022–2024)Tianjiao Li · Fudan University Shanghai Cancer Center6 papers (2022–2024)Ya Feng · Nankai University5 papers (2022–2024)Lizhong Yan · Nankai University4 papers (2022–2024)Changjun Wang · Guangdong Academy of Medical Sciences4 papers (2022–2024)Li Ding · South China Institute of Collaborative Innovation3 papers (2022–2024)Yin Li · Hunan Provincial Center for Disease Control and Prevention3 papers (2022–2023)Qiang Sun · Xuzhou Medical College3 papers (2022–2024)Yifan Zhang · Nankai University2 papers (2022–2022)Fangxu Zheng · Nankai University2 papers (2022–2022)Qiao Liu · Shandong University2 papers (2022–2024)Qiao Liu · Shandong University2 papers (2022–2022)Yupeng Zhang · Shandong University2 papers (2022–2022)Juan Yang · Guangzhou University of Chinese Medicine2 papers (2022–2024)Juan Yang · Xi'an Jiaotong University2 papers (2022–2022)Robert M. Cabrera · Baylor College of Medicine1 papers (2023–2023)Ying Lin · North Sichuan Medical University1 papers (2023–2023)